These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4514337)

  • 1. Treatment failures with L-dopa in Parkinsonism.
    Julsrud OJ
    Acta Neurol Scand Suppl; 1972; 51():123-4. PubMed ID: 4514337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 3. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of parkinsonism with levo-dopa: results in 302 cases.
    Newkirk TA; Magee KR
    Mich Med; 1971 Sep; 70(22):805-11. PubMed ID: 5141211
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychic manifestations during treatment of Parkinson's disease with L-dopa].
    Bonduelle M
    Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
    Rosati G; Agnetti V; Mura F; Granieri E
    Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
    [No Abstract]   [Full Text] [Related]  

  • 8. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Collateral effects of L-dopa treatment in patients with parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E
    Sist Nerv; 1970; 22(2):109-14. PubMed ID: 5504548
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A
    Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of Parkinsonism with L-dopa.
    Presthus J; Holmsen R
    Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal mouth-movements and oral damage associated with L-DOPA treatment.
    Sacks OW; Ross SJ; DePaola DP; Kohl MS
    Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 19. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.